Atlas Trials

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Clinical trial NCT00942422 · TERMINATED

Trial details

NCT number
NCT00942422
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
Start date
2009-11-01
Primary completion
2012-03-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.